Comments
Loading...
Intellia Therapeutics (NTLA) Forecast
NewsEarningsIntellia Therapeutics (NTLA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestIntellia Therapeutics (NASDAQ:NTLA) Stock Quotes, Forecast and News Summary
Intellia Therapeutics Stock (NASDAQ: NTLA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Intellia Therapeutics (NTLA) stock?
You can purchase shares of Intellia Therapeutics (NASDAQ:NTLA) through any online brokerage.
Who are Intellia Therapeutics (NTLA) competitors?
Other companies in Intellia Therapeutics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT) and Syndax Pharmaceuticals (NASDAQ:SNDX).
What is the forecast, or price target, for Intellia Therapeutics (NTLA) stock?
Intellia Therapeutics has a consensus price target of $59.50.
What is the current price for Intellia Therapeutics (NTLA)?
The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $12.36 last updated February 21, 2025 at 10:46 AM EST.
Does Intellia Therapeutics (NTLA) pay a dividend?
There are no upcoming dividends for Intellia Therapeutics.
When is Intellia Therapeutics (NASDAQ:NTLA) reporting earnings?
Intellia Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Intellia Therapeutics (NTLA) going to split?
There is no upcoming split for Intellia Therapeutics.
What sector and industry does Intellia Therapeutics (NTLA) operate in?
Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.